Yanhong Li

Title: Yanhong Li: Innovator in Sialidase Inhibitors and Enzymatic Methods

Introduction

Yanhong Li is a prominent inventor based in Davis, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of sialidase inhibitors and enzymatic methods for their preparation. With a total of 2 patents, his work has implications for cancer treatment and infectious diseases.

Latest Patents

Li's latest patents include innovative methods for creating sialidase inhibitors. One patent focuses on new 2-deoxy-2,3-dehydro-sialic acids and 2,7-anhydro-sialic acids, which are useful as sialidase inhibitors. The methods involve forming a reaction mixture that includes a glycoside acceptor, a sialic acid donor, and a sialyltransferase. The reaction mixture is maintained under specific conditions to form a sialoside, which is then treated with asialidase to yield the sialic acid product. Additionally, he has developed methods for the inhibition of sialidases and their application in treating cancer and infectious diseases. Another patent details a chemoenzymatic synthesis of heparin and heparan sulfate analogs, providing a one-pot multi-enzyme method for preparing UDP-sugars and oligosaccharides from simple sugar starting materials.

Career Highlights

Yanhong Li is affiliated with the University of California, where he conducts his research and development. His work has garnered attention for its potential applications in medical science, particularly in the treatment of diseases that involve sialidases.

Collaborations

Li collaborates with notable colleagues, including Xi Chelsea Chen and Hai Yu, who contribute to his research endeavors.

Conclusion

Yanhong Li's innovative work in the field of biochemistry, particularly in sialidase inhibitors and enzymatic methods, showcases his significant contributions to science and medicine. His patents reflect a commitment to advancing research that can lead to effective treatments for serious health conditions.